interferon	doxorubicin	4	3	false	none	7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  7.3 Hematologic/Bone Marrow Suppressive/Cytotoxic Agents    Coadministration of ganciclovir, interferon alfa, ribavirin, and other bone marrow suppressive or cytotoxic agents may increase the hematologic toxicity of zidovudine.  		none	3639	none	3639
interferon	doxorubicin	4	3	false	none	7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  7.3 Hematologic/Bone Marrow Suppressive/Cytotoxic Agents    Coadministration of ganciclovir, interferon alfa, ribavirin, and other bone marrow suppressive or cytotoxic agents may increase the hematologic toxicity of zidovudine.  		none	3639	none	3639
interferon	Doxorubicin	4	3	false	none	7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  7.3 Hematologic/Bone Marrow Suppressive/Cytotoxic Agents    Coadministration of ganciclovir, interferon alfa, ribavirin, and other bone marrow suppressive or cytotoxic agents may increase the hematologic toxicity of zidovudine.  		none	3639	none	3639
interferon	Doxorubicin	4	3	false	none	7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  7.3 Hematologic/Bone Marrow Suppressive/Cytotoxic Agents    Coadministration of ganciclovir, interferon alfa, ribavirin, and other bone marrow suppressive or cytotoxic agents may increase the hematologic toxicity of zidovudine.  		none	3639	none	3639
interferon	ganciclovir	4	4	false	none	7.3 Hematologic/Bone Marrow Suppressive/Cytotoxic Agents    Coadministration of ganciclovir, interferon alfa, ribavirin, and other bone marrow suppressive or cytotoxic agents may increase the hematologic toxicity of zidovudine.  		none	4678	none	4678
interferon	ganciclovir	4	4	false	none	7.3 Hematologic/Bone Marrow Suppressive/Cytotoxic Agents    Coadministration of ganciclovir, interferon alfa, ribavirin, and other bone marrow suppressive or cytotoxic agents may increase the hematologic toxicity of zidovudine.  		none	4678	none	4678
interferon	zidovudine	4	2	false	none	Nucleoside Analogues Affecting DNA Replication:  Some nucleoside analogues affecting DNA replication, such as ribavirin, antagonize the in vitro antiviral activity of zidovudine against HIV-1; concomitant use of such drugs should be avoided.  7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  7.3 Hematologic/Bone Marrow Suppressive/Cytotoxic Agents    Coadministration of ganciclovir, interferon alfa, ribavirin, and other bone marrow suppressive or cytotoxic agents may increase the hematologic toxicity of zidovudine.  		none	11413	none	11413
interferon	zidovudine	4	2	false	none	Nucleoside Analogues Affecting DNA Replication:  Some nucleoside analogues affecting DNA replication, such as ribavirin, antagonize the in vitro antiviral activity of zidovudine against HIV-1; concomitant use of such drugs should be avoided.  7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  7.3 Hematologic/Bone Marrow Suppressive/Cytotoxic Agents    Coadministration of ganciclovir, interferon alfa, ribavirin, and other bone marrow suppressive or cytotoxic agents may increase the hematologic toxicity of zidovudine.  		none	11413	none	11413
interferon	zidovudine	4	3	false	none	7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  7.3 Hematologic/Bone Marrow Suppressive/Cytotoxic Agents    Coadministration of ganciclovir, interferon alfa, ribavirin, and other bone marrow suppressive or cytotoxic agents may increase the hematologic toxicity of zidovudine.  		none	11413	none	11413
interferon	zidovudine	4	3	false	none	7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  7.3 Hematologic/Bone Marrow Suppressive/Cytotoxic Agents    Coadministration of ganciclovir, interferon alfa, ribavirin, and other bone marrow suppressive or cytotoxic agents may increase the hematologic toxicity of zidovudine.  		none	11413	none	11413
interferon	zidovudine	4	4	false	none	7.3 Hematologic/Bone Marrow Suppressive/Cytotoxic Agents    Coadministration of ganciclovir, interferon alfa, ribavirin, and other bone marrow suppressive or cytotoxic agents may increase the hematologic toxicity of zidovudine.  		none	11413	none	11413
interferon	zidovudine	4	4	false	none	7.3 Hematologic/Bone Marrow Suppressive/Cytotoxic Agents    Coadministration of ganciclovir, interferon alfa, ribavirin, and other bone marrow suppressive or cytotoxic agents may increase the hematologic toxicity of zidovudine.  		none	11413	none	11413
interferon	ribavirin	4	2	false	none	Nucleoside Analogues Affecting DNA Replication:  Some nucleoside analogues affecting DNA replication, such as ribavirin, antagonize the in vitro antiviral activity of zidovudine against HIV-1; concomitant use of such drugs should be avoided.  7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  7.3 Hematologic/Bone Marrow Suppressive/Cytotoxic Agents    Coadministration of ganciclovir, interferon alfa, ribavirin, and other bone marrow suppressive or cytotoxic agents may increase the hematologic toxicity of zidovudine.  		none	9344	none	9344
interferon	ribavirin	4	2	false	none	Nucleoside Analogues Affecting DNA Replication:  Some nucleoside analogues affecting DNA replication, such as ribavirin, antagonize the in vitro antiviral activity of zidovudine against HIV-1; concomitant use of such drugs should be avoided.  7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  7.3 Hematologic/Bone Marrow Suppressive/Cytotoxic Agents    Coadministration of ganciclovir, interferon alfa, ribavirin, and other bone marrow suppressive or cytotoxic agents may increase the hematologic toxicity of zidovudine.  		none	9344	none	9344
interferon	ribavirin	4	4	false	none	7.3 Hematologic/Bone Marrow Suppressive/Cytotoxic Agents    Coadministration of ganciclovir, interferon alfa, ribavirin, and other bone marrow suppressive or cytotoxic agents may increase the hematologic toxicity of zidovudine.  		none	9344	none	9344
interferon	ribavirin	4	4	false	none	7.3 Hematologic/Bone Marrow Suppressive/Cytotoxic Agents    Coadministration of ganciclovir, interferon alfa, ribavirin, and other bone marrow suppressive or cytotoxic agents may increase the hematologic toxicity of zidovudine.  		none	9344	none	9344
doxorubicin	Stavudine	3	1	false	none	7 DRUG INTERACTIONS    7.1 Antiretroviral Agents    Stavudine:  Concomitant use of zidovudine with stavudine should be avoided since an antagonistic relationship has been demonstrated in vitro.  Nucleoside Analogues Affecting DNA Replication:  Some nucleoside analogues affecting DNA replication, such as ribavirin, antagonize the in vitro antiviral activity of zidovudine against HIV-1; concomitant use of such drugs should be avoided.  7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  		3639	59763	3639	59763
doxorubicin	Stavudine	3	1	false	none	7 DRUG INTERACTIONS    7.1 Antiretroviral Agents    Stavudine:  Concomitant use of zidovudine with stavudine should be avoided since an antagonistic relationship has been demonstrated in vitro.  Nucleoside Analogues Affecting DNA Replication:  Some nucleoside analogues affecting DNA replication, such as ribavirin, antagonize the in vitro antiviral activity of zidovudine against HIV-1; concomitant use of such drugs should be avoided.  7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  		3639	59763	3639	59763
doxorubicin	Doxorubicin	3	3	false	none	7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  		3639	3639
doxorubicin	ganciclovir	3	4	false	none	7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  7.3 Hematologic/Bone Marrow Suppressive/Cytotoxic Agents    Coadministration of ganciclovir, interferon alfa, ribavirin, and other bone marrow suppressive or cytotoxic agents may increase the hematologic toxicity of zidovudine.  		3639	4678	3639	4678
doxorubicin	ganciclovir	3	4	false	none	7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  7.3 Hematologic/Bone Marrow Suppressive/Cytotoxic Agents    Coadministration of ganciclovir, interferon alfa, ribavirin, and other bone marrow suppressive or cytotoxic agents may increase the hematologic toxicity of zidovudine.  		3639	4678	3639	4678
doxorubicin	zidovudine	3	1	false	none	7 DRUG INTERACTIONS    7.1 Antiretroviral Agents    Stavudine:  Concomitant use of zidovudine with stavudine should be avoided since an antagonistic relationship has been demonstrated in vitro.  Nucleoside Analogues Affecting DNA Replication:  Some nucleoside analogues affecting DNA replication, such as ribavirin, antagonize the in vitro antiviral activity of zidovudine against HIV-1; concomitant use of such drugs should be avoided.  7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  		3639	11413	3639	11413
doxorubicin	zidovudine	3	1	false	none	7 DRUG INTERACTIONS    7.1 Antiretroviral Agents    Stavudine:  Concomitant use of zidovudine with stavudine should be avoided since an antagonistic relationship has been demonstrated in vitro.  Nucleoside Analogues Affecting DNA Replication:  Some nucleoside analogues affecting DNA replication, such as ribavirin, antagonize the in vitro antiviral activity of zidovudine against HIV-1; concomitant use of such drugs should be avoided.  7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  		3639	11413	3639	11413
doxorubicin	zidovudine	3	2	false	none	Nucleoside Analogues Affecting DNA Replication:  Some nucleoside analogues affecting DNA replication, such as ribavirin, antagonize the in vitro antiviral activity of zidovudine against HIV-1; concomitant use of such drugs should be avoided.  7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  		3639	11413	3639	11413
doxorubicin	zidovudine	3	2	false	none	Nucleoside Analogues Affecting DNA Replication:  Some nucleoside analogues affecting DNA replication, such as ribavirin, antagonize the in vitro antiviral activity of zidovudine against HIV-1; concomitant use of such drugs should be avoided.  7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  		3639	11413	3639	11413
doxorubicin	zidovudine	3	3	false	none	7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  		3639	11413	3639	11413
doxorubicin	zidovudine	3	3	false	none	7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  		3639	11413	3639	11413
doxorubicin	zidovudine	3	4	false	none	7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  7.3 Hematologic/Bone Marrow Suppressive/Cytotoxic Agents    Coadministration of ganciclovir, interferon alfa, ribavirin, and other bone marrow suppressive or cytotoxic agents may increase the hematologic toxicity of zidovudine.  		3639	11413	3639	11413
doxorubicin	zidovudine	3	4	false	none	7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  7.3 Hematologic/Bone Marrow Suppressive/Cytotoxic Agents    Coadministration of ganciclovir, interferon alfa, ribavirin, and other bone marrow suppressive or cytotoxic agents may increase the hematologic toxicity of zidovudine.  		3639	11413	3639	11413
doxorubicin	ribavirin	3	2	false	none	Nucleoside Analogues Affecting DNA Replication:  Some nucleoside analogues affecting DNA replication, such as ribavirin, antagonize the in vitro antiviral activity of zidovudine against HIV-1; concomitant use of such drugs should be avoided.  7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  		3639	9344	3639	9344
doxorubicin	ribavirin	3	2	false	none	Nucleoside Analogues Affecting DNA Replication:  Some nucleoside analogues affecting DNA replication, such as ribavirin, antagonize the in vitro antiviral activity of zidovudine against HIV-1; concomitant use of such drugs should be avoided.  7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  		3639	9344	3639	9344
doxorubicin	ribavirin	3	4	false	none	7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  7.3 Hematologic/Bone Marrow Suppressive/Cytotoxic Agents    Coadministration of ganciclovir, interferon alfa, ribavirin, and other bone marrow suppressive or cytotoxic agents may increase the hematologic toxicity of zidovudine.  		3639	9344	3639	9344
doxorubicin	ribavirin	3	4	false	none	7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  7.3 Hematologic/Bone Marrow Suppressive/Cytotoxic Agents    Coadministration of ganciclovir, interferon alfa, ribavirin, and other bone marrow suppressive or cytotoxic agents may increase the hematologic toxicity of zidovudine.  		3639	9344	3639	9344
doxorubicin	stavudine	3	1	false	none	7 DRUG INTERACTIONS    7.1 Antiretroviral Agents    Stavudine:  Concomitant use of zidovudine with stavudine should be avoided since an antagonistic relationship has been demonstrated in vitro.  Nucleoside Analogues Affecting DNA Replication:  Some nucleoside analogues affecting DNA replication, such as ribavirin, antagonize the in vitro antiviral activity of zidovudine against HIV-1; concomitant use of such drugs should be avoided.  7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  		3639	59763	3639	59763
doxorubicin	stavudine	3	1	false	none	7 DRUG INTERACTIONS    7.1 Antiretroviral Agents    Stavudine:  Concomitant use of zidovudine with stavudine should be avoided since an antagonistic relationship has been demonstrated in vitro.  Nucleoside Analogues Affecting DNA Replication:  Some nucleoside analogues affecting DNA replication, such as ribavirin, antagonize the in vitro antiviral activity of zidovudine against HIV-1; concomitant use of such drugs should be avoided.  7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  		3639	59763	3639	59763
Stavudine	Doxorubicin	1	3	false	none	7 DRUG INTERACTIONS    7.1 Antiretroviral Agents    Stavudine:  Concomitant use of zidovudine with stavudine should be avoided since an antagonistic relationship has been demonstrated in vitro.  Nucleoside Analogues Affecting DNA Replication:  Some nucleoside analogues affecting DNA replication, such as ribavirin, antagonize the in vitro antiviral activity of zidovudine against HIV-1; concomitant use of such drugs should be avoided.  7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  		59763	3639	59763	3639
Stavudine	Doxorubicin	1	3	false	none	7 DRUG INTERACTIONS    7.1 Antiretroviral Agents    Stavudine:  Concomitant use of zidovudine with stavudine should be avoided since an antagonistic relationship has been demonstrated in vitro.  Nucleoside Analogues Affecting DNA Replication:  Some nucleoside analogues affecting DNA replication, such as ribavirin, antagonize the in vitro antiviral activity of zidovudine against HIV-1; concomitant use of such drugs should be avoided.  7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  		59763	3639	59763	3639
Stavudine	zidovudine	1	1	false	none	7 DRUG INTERACTIONS    7.1 Antiretroviral Agents    Stavudine:  Concomitant use of zidovudine with stavudine should be avoided since an antagonistic relationship has been demonstrated in vitro.  		59763	11413	59763	11413
Stavudine	zidovudine	1	1	false	none	7 DRUG INTERACTIONS    7.1 Antiretroviral Agents    Stavudine:  Concomitant use of zidovudine with stavudine should be avoided since an antagonistic relationship has been demonstrated in vitro.  		59763	11413	59763	11413
Stavudine	zidovudine	1	2	false	none	7 DRUG INTERACTIONS    7.1 Antiretroviral Agents    Stavudine:  Concomitant use of zidovudine with stavudine should be avoided since an antagonistic relationship has been demonstrated in vitro.  Nucleoside Analogues Affecting DNA Replication:  Some nucleoside analogues affecting DNA replication, such as ribavirin, antagonize the in vitro antiviral activity of zidovudine against HIV-1; concomitant use of such drugs should be avoided.  		59763	11413	59763	11413
Stavudine	zidovudine	1	2	false	none	7 DRUG INTERACTIONS    7.1 Antiretroviral Agents    Stavudine:  Concomitant use of zidovudine with stavudine should be avoided since an antagonistic relationship has been demonstrated in vitro.  Nucleoside Analogues Affecting DNA Replication:  Some nucleoside analogues affecting DNA replication, such as ribavirin, antagonize the in vitro antiviral activity of zidovudine against HIV-1; concomitant use of such drugs should be avoided.  		59763	11413	59763	11413
Stavudine	zidovudine	1	3	false	none	7 DRUG INTERACTIONS    7.1 Antiretroviral Agents    Stavudine:  Concomitant use of zidovudine with stavudine should be avoided since an antagonistic relationship has been demonstrated in vitro.  Nucleoside Analogues Affecting DNA Replication:  Some nucleoside analogues affecting DNA replication, such as ribavirin, antagonize the in vitro antiviral activity of zidovudine against HIV-1; concomitant use of such drugs should be avoided.  7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  		59763	11413	59763	11413
Stavudine	zidovudine	1	3	false	none	7 DRUG INTERACTIONS    7.1 Antiretroviral Agents    Stavudine:  Concomitant use of zidovudine with stavudine should be avoided since an antagonistic relationship has been demonstrated in vitro.  Nucleoside Analogues Affecting DNA Replication:  Some nucleoside analogues affecting DNA replication, such as ribavirin, antagonize the in vitro antiviral activity of zidovudine against HIV-1; concomitant use of such drugs should be avoided.  7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  		59763	11413	59763	11413
Stavudine	ribavirin	1	2	false	none	7 DRUG INTERACTIONS    7.1 Antiretroviral Agents    Stavudine:  Concomitant use of zidovudine with stavudine should be avoided since an antagonistic relationship has been demonstrated in vitro.  Nucleoside Analogues Affecting DNA Replication:  Some nucleoside analogues affecting DNA replication, such as ribavirin, antagonize the in vitro antiviral activity of zidovudine against HIV-1; concomitant use of such drugs should be avoided.  		59763	9344	59763	9344
Stavudine	ribavirin	1	2	false	none	7 DRUG INTERACTIONS    7.1 Antiretroviral Agents    Stavudine:  Concomitant use of zidovudine with stavudine should be avoided since an antagonistic relationship has been demonstrated in vitro.  Nucleoside Analogues Affecting DNA Replication:  Some nucleoside analogues affecting DNA replication, such as ribavirin, antagonize the in vitro antiviral activity of zidovudine against HIV-1; concomitant use of such drugs should be avoided.  		59763	9344	59763	9344
Stavudine	stavudine	1	1	false	none	7 DRUG INTERACTIONS    7.1 Antiretroviral Agents    Stavudine:  Concomitant use of zidovudine with stavudine should be avoided since an antagonistic relationship has been demonstrated in vitro.  		59763	59763
Doxorubicin	ganciclovir	3	4	false	none	7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  7.3 Hematologic/Bone Marrow Suppressive/Cytotoxic Agents    Coadministration of ganciclovir, interferon alfa, ribavirin, and other bone marrow suppressive or cytotoxic agents may increase the hematologic toxicity of zidovudine.  		3639	4678	3639	4678
Doxorubicin	ganciclovir	3	4	false	none	7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  7.3 Hematologic/Bone Marrow Suppressive/Cytotoxic Agents    Coadministration of ganciclovir, interferon alfa, ribavirin, and other bone marrow suppressive or cytotoxic agents may increase the hematologic toxicity of zidovudine.  		3639	4678	3639	4678
Doxorubicin	zidovudine	3	1	false	none	7 DRUG INTERACTIONS    7.1 Antiretroviral Agents    Stavudine:  Concomitant use of zidovudine with stavudine should be avoided since an antagonistic relationship has been demonstrated in vitro.  Nucleoside Analogues Affecting DNA Replication:  Some nucleoside analogues affecting DNA replication, such as ribavirin, antagonize the in vitro antiviral activity of zidovudine against HIV-1; concomitant use of such drugs should be avoided.  7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  		3639	11413	3639	11413
Doxorubicin	zidovudine	3	1	false	none	7 DRUG INTERACTIONS    7.1 Antiretroviral Agents    Stavudine:  Concomitant use of zidovudine with stavudine should be avoided since an antagonistic relationship has been demonstrated in vitro.  Nucleoside Analogues Affecting DNA Replication:  Some nucleoside analogues affecting DNA replication, such as ribavirin, antagonize the in vitro antiviral activity of zidovudine against HIV-1; concomitant use of such drugs should be avoided.  7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  		3639	11413	3639	11413
Doxorubicin	zidovudine	3	2	false	none	Nucleoside Analogues Affecting DNA Replication:  Some nucleoside analogues affecting DNA replication, such as ribavirin, antagonize the in vitro antiviral activity of zidovudine against HIV-1; concomitant use of such drugs should be avoided.  7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  		3639	11413	3639	11413
Doxorubicin	zidovudine	3	2	false	none	Nucleoside Analogues Affecting DNA Replication:  Some nucleoside analogues affecting DNA replication, such as ribavirin, antagonize the in vitro antiviral activity of zidovudine against HIV-1; concomitant use of such drugs should be avoided.  7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  		3639	11413	3639	11413
Doxorubicin	zidovudine	3	3	false	none	7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  		3639	11413	3639	11413
Doxorubicin	zidovudine	3	3	false	none	7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  		3639	11413	3639	11413
Doxorubicin	zidovudine	3	4	false	none	7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  7.3 Hematologic/Bone Marrow Suppressive/Cytotoxic Agents    Coadministration of ganciclovir, interferon alfa, ribavirin, and other bone marrow suppressive or cytotoxic agents may increase the hematologic toxicity of zidovudine.  		3639	11413	3639	11413
Doxorubicin	zidovudine	3	4	false	none	7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  7.3 Hematologic/Bone Marrow Suppressive/Cytotoxic Agents    Coadministration of ganciclovir, interferon alfa, ribavirin, and other bone marrow suppressive or cytotoxic agents may increase the hematologic toxicity of zidovudine.  		3639	11413	3639	11413
Doxorubicin	ribavirin	3	2	false	none	Nucleoside Analogues Affecting DNA Replication:  Some nucleoside analogues affecting DNA replication, such as ribavirin, antagonize the in vitro antiviral activity of zidovudine against HIV-1; concomitant use of such drugs should be avoided.  7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  		3639	9344	3639	9344
Doxorubicin	ribavirin	3	2	false	none	Nucleoside Analogues Affecting DNA Replication:  Some nucleoside analogues affecting DNA replication, such as ribavirin, antagonize the in vitro antiviral activity of zidovudine against HIV-1; concomitant use of such drugs should be avoided.  7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  		3639	9344	3639	9344
Doxorubicin	ribavirin	3	4	false	none	7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  7.3 Hematologic/Bone Marrow Suppressive/Cytotoxic Agents    Coadministration of ganciclovir, interferon alfa, ribavirin, and other bone marrow suppressive or cytotoxic agents may increase the hematologic toxicity of zidovudine.  		3639	9344	3639	9344
Doxorubicin	ribavirin	3	4	false	none	7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  7.3 Hematologic/Bone Marrow Suppressive/Cytotoxic Agents    Coadministration of ganciclovir, interferon alfa, ribavirin, and other bone marrow suppressive or cytotoxic agents may increase the hematologic toxicity of zidovudine.  		3639	9344	3639	9344
Doxorubicin	stavudine	3	1	false	none	7 DRUG INTERACTIONS    7.1 Antiretroviral Agents    Stavudine:  Concomitant use of zidovudine with stavudine should be avoided since an antagonistic relationship has been demonstrated in vitro.  Nucleoside Analogues Affecting DNA Replication:  Some nucleoside analogues affecting DNA replication, such as ribavirin, antagonize the in vitro antiviral activity of zidovudine against HIV-1; concomitant use of such drugs should be avoided.  7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  		3639	59763	3639	59763
Doxorubicin	stavudine	3	1	false	none	7 DRUG INTERACTIONS    7.1 Antiretroviral Agents    Stavudine:  Concomitant use of zidovudine with stavudine should be avoided since an antagonistic relationship has been demonstrated in vitro.  Nucleoside Analogues Affecting DNA Replication:  Some nucleoside analogues affecting DNA replication, such as ribavirin, antagonize the in vitro antiviral activity of zidovudine against HIV-1; concomitant use of such drugs should be avoided.  7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  		3639	59763	3639	59763
ganciclovir	zidovudine	4	2	false	none	Nucleoside Analogues Affecting DNA Replication:  Some nucleoside analogues affecting DNA replication, such as ribavirin, antagonize the in vitro antiviral activity of zidovudine against HIV-1; concomitant use of such drugs should be avoided.  7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  7.3 Hematologic/Bone Marrow Suppressive/Cytotoxic Agents    Coadministration of ganciclovir, interferon alfa, ribavirin, and other bone marrow suppressive or cytotoxic agents may increase the hematologic toxicity of zidovudine.  		4678	11413	4678	11413
ganciclovir	zidovudine	4	2	false	none	Nucleoside Analogues Affecting DNA Replication:  Some nucleoside analogues affecting DNA replication, such as ribavirin, antagonize the in vitro antiviral activity of zidovudine against HIV-1; concomitant use of such drugs should be avoided.  7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  7.3 Hematologic/Bone Marrow Suppressive/Cytotoxic Agents    Coadministration of ganciclovir, interferon alfa, ribavirin, and other bone marrow suppressive or cytotoxic agents may increase the hematologic toxicity of zidovudine.  		4678	11413	4678	11413
ganciclovir	zidovudine	4	3	false	none	7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  7.3 Hematologic/Bone Marrow Suppressive/Cytotoxic Agents    Coadministration of ganciclovir, interferon alfa, ribavirin, and other bone marrow suppressive or cytotoxic agents may increase the hematologic toxicity of zidovudine.  		4678	11413	4678	11413
ganciclovir	zidovudine	4	3	false	none	7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  7.3 Hematologic/Bone Marrow Suppressive/Cytotoxic Agents    Coadministration of ganciclovir, interferon alfa, ribavirin, and other bone marrow suppressive or cytotoxic agents may increase the hematologic toxicity of zidovudine.  		4678	11413	4678	11413
ganciclovir	zidovudine	4	4	false	none	7.3 Hematologic/Bone Marrow Suppressive/Cytotoxic Agents    Coadministration of ganciclovir, interferon alfa, ribavirin, and other bone marrow suppressive or cytotoxic agents may increase the hematologic toxicity of zidovudine.  		4678	11413	4678	11413
ganciclovir	zidovudine	4	4	false	none	7.3 Hematologic/Bone Marrow Suppressive/Cytotoxic Agents    Coadministration of ganciclovir, interferon alfa, ribavirin, and other bone marrow suppressive or cytotoxic agents may increase the hematologic toxicity of zidovudine.  		4678	11413	4678	11413
ganciclovir	ribavirin	4	2	false	none	Nucleoside Analogues Affecting DNA Replication:  Some nucleoside analogues affecting DNA replication, such as ribavirin, antagonize the in vitro antiviral activity of zidovudine against HIV-1; concomitant use of such drugs should be avoided.  7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  7.3 Hematologic/Bone Marrow Suppressive/Cytotoxic Agents    Coadministration of ganciclovir, interferon alfa, ribavirin, and other bone marrow suppressive or cytotoxic agents may increase the hematologic toxicity of zidovudine.  		4678	9344	4678	9344
ganciclovir	ribavirin	4	2	false	none	Nucleoside Analogues Affecting DNA Replication:  Some nucleoside analogues affecting DNA replication, such as ribavirin, antagonize the in vitro antiviral activity of zidovudine against HIV-1; concomitant use of such drugs should be avoided.  7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  7.3 Hematologic/Bone Marrow Suppressive/Cytotoxic Agents    Coadministration of ganciclovir, interferon alfa, ribavirin, and other bone marrow suppressive or cytotoxic agents may increase the hematologic toxicity of zidovudine.  		4678	9344	4678	9344
ganciclovir	ribavirin	4	4	false	none	7.3 Hematologic/Bone Marrow Suppressive/Cytotoxic Agents    Coadministration of ganciclovir, interferon alfa, ribavirin, and other bone marrow suppressive or cytotoxic agents may increase the hematologic toxicity of zidovudine.  		4678	9344	4678	9344
ganciclovir	ribavirin	4	4	false	none	7.3 Hematologic/Bone Marrow Suppressive/Cytotoxic Agents    Coadministration of ganciclovir, interferon alfa, ribavirin, and other bone marrow suppressive or cytotoxic agents may increase the hematologic toxicity of zidovudine.  		4678	9344	4678	9344
zidovudine	ribavirin	1	2	false	none	7 DRUG INTERACTIONS    7.1 Antiretroviral Agents    Stavudine:  Concomitant use of zidovudine with stavudine should be avoided since an antagonistic relationship has been demonstrated in vitro.  Nucleoside Analogues Affecting DNA Replication:  Some nucleoside analogues affecting DNA replication, such as ribavirin, antagonize the in vitro antiviral activity of zidovudine against HIV-1; concomitant use of such drugs should be avoided.  		11413	9344	11413	9344
zidovudine	ribavirin	1	2	false	none	7 DRUG INTERACTIONS    7.1 Antiretroviral Agents    Stavudine:  Concomitant use of zidovudine with stavudine should be avoided since an antagonistic relationship has been demonstrated in vitro.  Nucleoside Analogues Affecting DNA Replication:  Some nucleoside analogues affecting DNA replication, such as ribavirin, antagonize the in vitro antiviral activity of zidovudine against HIV-1; concomitant use of such drugs should be avoided.  		11413	9344	11413	9344
zidovudine	ribavirin	2	2	false	none	Nucleoside Analogues Affecting DNA Replication:  Some nucleoside analogues affecting DNA replication, such as ribavirin, antagonize the in vitro antiviral activity of zidovudine against HIV-1; concomitant use of such drugs should be avoided.  		11413	9344	11413	9344
zidovudine	ribavirin	2	2	false	none	Nucleoside Analogues Affecting DNA Replication:  Some nucleoside analogues affecting DNA replication, such as ribavirin, antagonize the in vitro antiviral activity of zidovudine against HIV-1; concomitant use of such drugs should be avoided.  		11413	9344	11413	9344
zidovudine	ribavirin	2	4	false	none	Nucleoside Analogues Affecting DNA Replication:  Some nucleoside analogues affecting DNA replication, such as ribavirin, antagonize the in vitro antiviral activity of zidovudine against HIV-1; concomitant use of such drugs should be avoided.  7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  7.3 Hematologic/Bone Marrow Suppressive/Cytotoxic Agents    Coadministration of ganciclovir, interferon alfa, ribavirin, and other bone marrow suppressive or cytotoxic agents may increase the hematologic toxicity of zidovudine.  		11413	9344	11413	9344
zidovudine	ribavirin	2	4	false	none	Nucleoside Analogues Affecting DNA Replication:  Some nucleoside analogues affecting DNA replication, such as ribavirin, antagonize the in vitro antiviral activity of zidovudine against HIV-1; concomitant use of such drugs should be avoided.  7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  7.3 Hematologic/Bone Marrow Suppressive/Cytotoxic Agents    Coadministration of ganciclovir, interferon alfa, ribavirin, and other bone marrow suppressive or cytotoxic agents may increase the hematologic toxicity of zidovudine.  		11413	9344	11413	9344
zidovudine	ribavirin	3	2	false	none	Nucleoside Analogues Affecting DNA Replication:  Some nucleoside analogues affecting DNA replication, such as ribavirin, antagonize the in vitro antiviral activity of zidovudine against HIV-1; concomitant use of such drugs should be avoided.  7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  		11413	9344	11413	9344
zidovudine	ribavirin	3	2	false	none	Nucleoside Analogues Affecting DNA Replication:  Some nucleoside analogues affecting DNA replication, such as ribavirin, antagonize the in vitro antiviral activity of zidovudine against HIV-1; concomitant use of such drugs should be avoided.  7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  		11413	9344	11413	9344
zidovudine	ribavirin	3	4	false	none	7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  7.3 Hematologic/Bone Marrow Suppressive/Cytotoxic Agents    Coadministration of ganciclovir, interferon alfa, ribavirin, and other bone marrow suppressive or cytotoxic agents may increase the hematologic toxicity of zidovudine.  		11413	9344	11413	9344
zidovudine	ribavirin	3	4	false	none	7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  7.3 Hematologic/Bone Marrow Suppressive/Cytotoxic Agents    Coadministration of ganciclovir, interferon alfa, ribavirin, and other bone marrow suppressive or cytotoxic agents may increase the hematologic toxicity of zidovudine.  		11413	9344	11413	9344
zidovudine	ribavirin	4	2	false	none	Nucleoside Analogues Affecting DNA Replication:  Some nucleoside analogues affecting DNA replication, such as ribavirin, antagonize the in vitro antiviral activity of zidovudine against HIV-1; concomitant use of such drugs should be avoided.  7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  7.3 Hematologic/Bone Marrow Suppressive/Cytotoxic Agents    Coadministration of ganciclovir, interferon alfa, ribavirin, and other bone marrow suppressive or cytotoxic agents may increase the hematologic toxicity of zidovudine.  		11413	9344	11413	9344
zidovudine	ribavirin	4	2	false	none	Nucleoside Analogues Affecting DNA Replication:  Some nucleoside analogues affecting DNA replication, such as ribavirin, antagonize the in vitro antiviral activity of zidovudine against HIV-1; concomitant use of such drugs should be avoided.  7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  7.3 Hematologic/Bone Marrow Suppressive/Cytotoxic Agents    Coadministration of ganciclovir, interferon alfa, ribavirin, and other bone marrow suppressive or cytotoxic agents may increase the hematologic toxicity of zidovudine.  		11413	9344	11413	9344
zidovudine	ribavirin	4	4	false	none	7.3 Hematologic/Bone Marrow Suppressive/Cytotoxic Agents    Coadministration of ganciclovir, interferon alfa, ribavirin, and other bone marrow suppressive or cytotoxic agents may increase the hematologic toxicity of zidovudine.  		11413	9344	11413	9344
zidovudine	ribavirin	4	4	false	none	7.3 Hematologic/Bone Marrow Suppressive/Cytotoxic Agents    Coadministration of ganciclovir, interferon alfa, ribavirin, and other bone marrow suppressive or cytotoxic agents may increase the hematologic toxicity of zidovudine.  		11413	9344	11413	9344
zidovudine	stavudine	1	1	false	none	7 DRUG INTERACTIONS    7.1 Antiretroviral Agents    Stavudine:  Concomitant use of zidovudine with stavudine should be avoided since an antagonistic relationship has been demonstrated in vitro.  		11413	59763	11413	59763
zidovudine	stavudine	1	1	false	none	7 DRUG INTERACTIONS    7.1 Antiretroviral Agents    Stavudine:  Concomitant use of zidovudine with stavudine should be avoided since an antagonistic relationship has been demonstrated in vitro.  		11413	59763	11413	59763
zidovudine	stavudine	2	1	false	none	7 DRUG INTERACTIONS    7.1 Antiretroviral Agents    Stavudine:  Concomitant use of zidovudine with stavudine should be avoided since an antagonistic relationship has been demonstrated in vitro.  Nucleoside Analogues Affecting DNA Replication:  Some nucleoside analogues affecting DNA replication, such as ribavirin, antagonize the in vitro antiviral activity of zidovudine against HIV-1; concomitant use of such drugs should be avoided.  		11413	59763	11413	59763
zidovudine	stavudine	2	1	false	none	7 DRUG INTERACTIONS    7.1 Antiretroviral Agents    Stavudine:  Concomitant use of zidovudine with stavudine should be avoided since an antagonistic relationship has been demonstrated in vitro.  Nucleoside Analogues Affecting DNA Replication:  Some nucleoside analogues affecting DNA replication, such as ribavirin, antagonize the in vitro antiviral activity of zidovudine against HIV-1; concomitant use of such drugs should be avoided.  		11413	59763	11413	59763
zidovudine	stavudine	3	1	false	none	7 DRUG INTERACTIONS    7.1 Antiretroviral Agents    Stavudine:  Concomitant use of zidovudine with stavudine should be avoided since an antagonistic relationship has been demonstrated in vitro.  Nucleoside Analogues Affecting DNA Replication:  Some nucleoside analogues affecting DNA replication, such as ribavirin, antagonize the in vitro antiviral activity of zidovudine against HIV-1; concomitant use of such drugs should be avoided.  7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  		11413	59763	11413	59763
zidovudine	stavudine	3	1	false	none	7 DRUG INTERACTIONS    7.1 Antiretroviral Agents    Stavudine:  Concomitant use of zidovudine with stavudine should be avoided since an antagonistic relationship has been demonstrated in vitro.  Nucleoside Analogues Affecting DNA Replication:  Some nucleoside analogues affecting DNA replication, such as ribavirin, antagonize the in vitro antiviral activity of zidovudine against HIV-1; concomitant use of such drugs should be avoided.  7.2 Doxorubicin    Concomitant use of zidovudine with doxorubicin should be avoided since an antagonistic relationship has been demonstrated in vitro.  		11413	59763	11413	59763
ribavirin	stavudine	2	1	false	none	7 DRUG INTERACTIONS    7.1 Antiretroviral Agents    Stavudine:  Concomitant use of zidovudine with stavudine should be avoided since an antagonistic relationship has been demonstrated in vitro.  Nucleoside Analogues Affecting DNA Replication:  Some nucleoside analogues affecting DNA replication, such as ribavirin, antagonize the in vitro antiviral activity of zidovudine against HIV-1; concomitant use of such drugs should be avoided.  		9344	59763	9344	59763
ribavirin	stavudine	2	1	false	none	7 DRUG INTERACTIONS    7.1 Antiretroviral Agents    Stavudine:  Concomitant use of zidovudine with stavudine should be avoided since an antagonistic relationship has been demonstrated in vitro.  Nucleoside Analogues Affecting DNA Replication:  Some nucleoside analogues affecting DNA replication, such as ribavirin, antagonize the in vitro antiviral activity of zidovudine against HIV-1; concomitant use of such drugs should be avoided.  		9344	59763	9344	59763
